Three years ago, the World Bank issued new bonds to raise funds that could be used to help poor countries fight pandemics. The money is still sitting on the sidelines. Critics question whether the money can be put to effective use.
Read More
Climate change is going to raise the risk that Ebola will spread farther and reach areas previously unaffected by the virus, according to a study published Tuesday in the journal Nature Communications.
Read More
Two new Ebola treatments are proving so effective they are being offered to all patients in the Democratic Republic of Congo, where the current outbreak is the second-deadliest ever.
Read More
Drug giant GlaxoSmithKline is stopping research into vaccines to treat Ebola and is turning over related projects to the Sabin Vaccine Institute.
Read More
Grifols, the global biotherapeutics company with major operations in North Carolina, announced today that it will begin production of a plasma-derived treatment to battle the Ebola virus for the country of Liberia at its flagship Clayton manufacturing site.
Read More
BioCryst Pharmaceuticals Inc. has been given an additional $3.5 million by the federal government to support clinical trials using one of the company’s signature drugs in the treatment of yellow fever.
Read MoreAn Ebola outbreak in the Democratic Republic of Congo (DRC) has entered a “new phase,” after it spread to a large city, the country’s health minister, Dr. Oly Ilunga Kalenga, reports.
Read MoreThe World Health Organization is preparing for the “worst case scenario” as it continues to respond to the Ebola outbreak in the Democratic Republic of Congo.
Read More
